InVivium Capital
Overview
InVivium Capital is a venture capital investment firm based in Chicago, Illinois, that focuses on investments in healthcare and life sciences. Through its seed and venture development programs, the firm provides access and forms lasting relationships from seed through the later stages of growth. They seek transformative solutions that provide a step-change in value to patients, payers, providers, pharma and biotech and invest across the spectrum of innovation in healthcare and life sciences, including biotechnology, medical devices, tools and diagnostics, and healthcare IT. InVivium's investment scope spans the US and can also include opportunistic investments in global and under-ventured geographies.
Portfolio Companies
4
Website
invivium.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Onchilles Pharma | Nov 2025 | Series A Extension | Co-investor |
| Grove Biopharma | Apr 2025 | Series A | Co-investor |
| Hinge Bio | Jan 2025 | Series A | Co-investor |
| Virtual Incision | Sep 2023 | Series C Extension | Lead |
| Virtual Incision | Jun 2023 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.